Navigating the Complexities of Opioid Use Disorder in Aging Adults: Comorbid Psychiatric Diagnoses and Changing DEA Regulations-View Presentation Slides

View Presentation Slides

Pdf Summary

The document provides a comprehensive overview of a webinar conducted by the American Psychiatric Association on the complexities of opioid use disorder (OUD), particularly focusing on comorbid psychiatric diagnoses, implications for older adults, and changes in DEA regulations. 

Key highlights from the webinar include:

<strong>Comorbid Psychiatric Diagnoses with OUD</strong>: Participants were trained to identify common comorbid psychiatric diagnoses associated with opioid use disorder.

<strong>Impact on Older Adults</strong>: The webinar detailed how opioid misuse significantly affects the older population, with a focus on severe mental illness (SMI) and the increased risk this group faces for inadequate healthcare and inappropriate prescriptions. The prevalence of related disorders such as major depression is notable within this demographic.

<strong>Changing DEA Regulations</strong>: Updates in Drug Enforcement Agency (DEA) requirements were discussed, specifically the Mainstreaming Addiction Treatment (MAT) Act and Medication Access and Training Expansion (MATE) Act which aim to increase prescribers and establish new training protocols for buprenorphine prescription, respectively.

<strong>Pharmacokinetics and Risks</strong>: Age-related changes impacting opioid metabolism and the increased sensitivity to opioids in older adults were covered, highlighting risks like adverse effects and the need for careful prescribing.

<strong>Medication Assisted Treatment (MAT)</strong>: Special emphasis was given to the benefits of using buprenorphine for treating OUD in older adults due to its safer profile and decreased likelihood of adverse gastrointestinal effects.

<strong>Webinar Logistics</strong>: The document outlines how participants can engage, download materials, and claim continuing education credits. It also mentions an upcoming webinar on embedding peers in mobile crisis teams and provides resources for further inquiry and program implementation for treating OUD among those with serious mental illness.

Overall, the webinar delivered valuable insights into the growing opioid crisis intersecting with psychiatric co-morbidities and the geriatric population, alongside evolving guidelines for treatment and prescription practices.

Keywords

Opioid Use Disorder

Comorbid Psychiatric Diagnoses

Older Adults

DEA Regulations

Mainstreaming Addiction Treatment Act

Medication Access and Training Expansion Act

Buprenorphine

Medication Assisted Treatment

Pharmacokinetics

Severe Mental Illness